Graeme Meintjes

Clinical Professor

Queen Mary University of London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Graeme Meintjes is a Clinical Professor at Queen Mary University of London, UK. His research areas focus on tuberculosis and HIV, including the evaluation of treatment guidelines, patient preferences for therapy, and the diagnostic accuracy of various tests. His recent publications address key issues such as drug resistance in treatment-experienced patients and the co-infection challenges of tuberculosis and HIV.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Collaborators (2)

Ahizechukwu C. Eke, MD PhD

Associate Professor of Maternal Fetal Medicine

Johns Hopkins University School of Medicine

UNITED STATES

View details

Naomi Walker

Senior Clinical Lecturer

Liverpool School of Tropical Medicine

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Graeme Meintjes

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Patient and provider preferences for long-acting TB preventive therapy

Standard of care in advanced HIV disease: review of HIV treatment guidelines in sub-Saharan African countries—an extension study of eight countries

Lipid and Glucose Profiles in Pregnant Women With HIV on Tenofovir-based Antiretroviral Therapy.

Resistance to Dolutegravir in Treatment-experienced Patients in South Africa: A Retrospective Cohort Study.

Brief Report: Resistance to Dolutegravir in Treatment-Experienced Patients in South Africa: A Retrospective Cohort Study

Tuberculosis and HIV coinfection: progress and challenges towards reducing incidence and mortality.

World TB Day 2025 Theme "Yes! We Can End TB: Commit, Invest, Deliver" can be made a reality through concerted global efforts to advance diagnosis, treatment and research of tuberculosis infection and disease.

A Prospective Evaluation of the Diagnostic Accuracy of the Point-of-Care VISITECT CD4 Advanced Disease Test in 7 Countries

Development and validation of a time-varying correction factor for QT interval assessment in drug-resistant tuberculosis patients.

Elevated Plasma Matrix Metalloproteinases Are Associated With Mycobacterium tuberculosis Bloodstream Infection and Mortality in Human Immunodeficiency Virus–Associated Tuberculosis

Collaborators (2)

Ahizechukwu C. Eke, MD PhD

Naomi Walker

Make your next move.